Advice You - Business

In addition to enteral nutrition claims for medical billing, there are also claims that fall under the category of parenteral nutrition. Thes

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

e claims are sent using GP0 records instead of GE0 records. The first question that many people ask is what the difference is between enteral

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

nutrition and parental nutrition. So before we go into the GP0 CMN in detail, a brief explanation of the differences between the two is prob

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ably in order.

Enteral nutrition is where the feeding of the patient is done through feeding tubes. The food still goes through the patient'

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s digestive system, including the stomach. With parental nutrition, the method of feeding is done by intravenous. The food totally bypasses

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

the digestive system. This type of feeding is usually done with patients who have just had surgery and can't have any food go through their s

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

tomach. It is also done in cases where the patient is critically ill. Having cleared that up, we'll now go into our detailed review of the G

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

0 record.

GP0 field 1, positions 1 - 3, is the record type. This field is to be filled with GP0. Note: This record must come after the F re

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

cords for this patient and claim. Failure to do this will result in the claim being denied.

GP0 field 2, positions 4 - 5, is the sequence nu

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

mber. This is the number of the CMN itself. There can be as many as 99 CMNs sent with a claim. Each one would be designated as GP0-01, GP0-

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

02, etc.

GP0 field 3, positions 6 - 22, is the patient control number. This must be the same patient ID number that is transmitted in the CA

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

0 record and all subsequent records containing a patient ID.

GP0 field 4, position 23, is the certification type. For parental nutrition, th

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ere can be three valid responses. If this is an initial certification, this field goes over as an I. If it is a renewal certification, it go

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

es over as an R. If it is a revised certification, it goes over as an S.

GP0 field 5, positions 24 - 31, is the date therapy began. This is

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

the actual date that the patient began parental therapy. The date can go over as yyyymmdd or mmddyyyy, depending on the requirements of the c

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

arrier.

GP0 field 6, positions 32 - 33, is the therapy duration field. This field tells the carrier the estimated time that the patient will

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

be on parental nutrition. It should be noted that even though this is just an estimate, the field must still be filled in.

GP0 field 7, pos

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

itions 34 - 41, is the last date of certification field. This field tells the carrier the last date that this CMN was certified prior to this

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

. The date can go over as yyyymmdd or mmddyyyy, depending on the requirements of the carrier.

In our next installment of medical billing usi

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ng electronic transmission media and NSF 3.01 specifications, we'll be continuing our review of the GP0 record, picking up with field number 8

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/2272/adviceyou-Medical-Billing--GP0-Record-Fields-1-Through-7.html">Medical Billing - GP0 Record Fields 1 Through 7</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/2272/adviceyou-Medical-Billing--GP0-Record-Fields-1-Through-7.html]Medical Billing - GP0 Record Fields 1 Through 7[/url]

The practice of accepting credit cards is not devoid of risk. In order to avoid falling victim to credit card fraud, it is best for merchants to exercise caution and investigate when necessary. A little credit card fraud prevention can save a lot of money ... and grief.

Very few people know that there is a hidden relationship between the success of a business venture and hypnosis. While this may not be that evident, it is actually an integral part of every successful business venture.

I've got a confession to make - I was scammed by a company promising me I can stay at home and type data into forms and make over two hundred dollars a day.

Tags

Links

Advice You - Medical Billing - GP0 Record Fields 1 Through 7

Related Articles: